Results 41 to 50 of about 5,422,157 (191)
Nutrient management in the intrapartum period in maternal maple syrup urine disease
Women with congenital amino acid disorders, including maple syrup urine disease (MSUD), are at risk of metabolic crisis at delivery. There are still only a few case reports of maternal MSUD globally, and we are the first to report the successful ...
Chika Takano +10 more
doaj +1 more source
Maple syrup urine disease: Role of diffusion-weighted magnetic resonance imaging [PDF]
Maple syrup urine disease (MSUD)/leucine encephalopathy is an inborn error of amino acid metabolism resulting in neurotransmitter depletion, disrupted brain growth and development.
Prasad, B Johny +3 more
core +1 more source
Objectives: Accurate management of metabolic decompensation in maple syrup urine disease (MSUD) has a crucial role, as acute attacks can cause neurological sequels and can be life threatening.
CANSEVER, Mehmet Şerif +14 more
core +1 more source
A Case of Multiple Mitochondrial Dysfunctions Syndrome 1 and Review of the Literature
ABSTRACT Multiple mitochondrial dysfunctions syndrome 1 (MMDS1, MIM #605711) due to NFU1 gene defects is an ultra‐rare autosomal recessive inborn error of metabolism associated with reduced function of NFU1 iron–sulfur cluster (ISC) scaffold protein.
Charles R. DiFalco +6 more
wiley +1 more source
ABSTRACT Nutritional therapy is critical in managing inherited metabolic diseases (IMDs), and includes specialized diets and single nutritional therapy products (sNTPs) such as vitamins, cofactors, and amino acids. Many sNTPs function as medicines, but are regulated as food (e.g., food supplements), which can limit access, reimbursement, and consistent
Nina N. Stolwijk +39 more
wiley +1 more source
Implementation of a Novel Multi‐Center Pediatric Liver Transplant Collaborative Network
Collaborative program development. Each program was developed in successive steps from initial education and protocol development with established punch lists and metrics for program launch. Once the program was launched with onsite and virtual support, regular operations meetings of all clinical and administrative team members afforded necessary ...
Kyle A. Soltys +18 more
wiley +1 more source
Maple syrup urine disease (MSUD) is a rare autosomal recessive metabolic disorder. This disorder is usually caused by mutations in any one of the genes; BCKDHA, BCKDHB and DBT, which represent E1α, E1β and E2 subunits of the branched-chain α-keto acid ...
Ernie Zuraida Ali, Lock-Hock Ngu
doaj +1 more source
MRI brain in maple syrup urine disease
A neonate presented with vomiting, poor feeding, and progressive lethargy during the early neonatal period, with metabolic acidosis but otherwise unremarkable routine biochemistry. Magnetic resonance imaging (MRI) of the brain showed symmetrical areas of
Tripti Prajapati, Rahul Dev
doaj +1 more source
A Quantitative Systems Pharmacology Model of Human Leucine Metabolism
ABSTRACT Branched‐chain amino acids (BCAAs) are essential dietary components that humans cannot synthesize. Altered BCAA levels have been associated with biomarkers or potential risk factors in several metabolic disorders, including insulin resistance, type 2 diabetes, obesity, and cardiovascular disease.
J. Cody Herron +10 more
wiley +1 more source
Dietary Management of a Patient with Both Maple Syrup Urine Disease and Type I Diabetes [PDF]
Maple Syrup Urine disease (MSUD) is caused by the deficiency of the branched chain 2-ketoacid dehydrogenase complex. Type I diabetes mellitus (TIDM) is a chronic illness characterized by the body’s inability to produce insulin due to the autoimmune ...
Unal, ÖZLEM +7 more
core +1 more source

